Table 1 Patient and clinical characteristics (n = 10)
Characteristic | Number (%) of patients or Median (range) |
|---|---|
Age (y) | 60 (38–71) |
Sex | |
Male | 6 (60%) |
Female | 4 (40%) |
Primary tumor | |
Pancreas | 4 (40%) |
Intestine | 2 (20%) |
Lung | 2 (20%) |
CUP | 2 20%) |
Tumor grade | |
G1 | 2 (20%) |
G1/G2 (i.e., Ki-67 < 5%) | 2 (20%) |
G2 | 6 (60%) |
Ki-67 (%) | 5 (1–18) |
Ongoing therapy at time of scan | |
SSA only | 6 (60%) |
SSA and everolimus | 2 (20%) |
None | 2 (20%) |
Interval [18F]AlF-OC and [68Ga]Ga-DOTATATE scan (days) | 9.5 (− 8 to + 35) |
TNM stage | |
T (0/1/2/3/4) | T (8/0/2/0) |
N (0/1/2/3) | N (4/5/0/1) |
M (0/M1a/M1b/M1c) | M (1/1/2/6) |